Intra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and Metastasis

by Sandra Cascio, Olivera J. Finn
Published 2016-10-01

Complex of MUC1, CIN85 and Cbl in Colon Cancer Progression and Metastasis

by Sandra Cascio, Olivera J. Finn
Published 2015-02-01

Global inhibition of DC priming capacity in the spleen of self-antigen vaccinated mice requires IL-10

by Douglas Matthew Marvel, Olivera J. Finn
Published 2014-02-01

Editorial: Myeloid Derived Suppressor Cells as Disease Modulators

by Olivera J. Finn, Augusto C. Ochoa
Published 2020-01-01

Cloning and Expression of Human Membrane-Bound and Soluble Engineered T Cell Receptors for Immunotherapy

by Nehad M. Alajez, Saman Eghtesad, Olivera J. Finn
Published 2006-01-01

mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting

by Jason J. Lohmueller, James D. Ham, Michael Kvorjak, Olivera J. Finn
Published 2018-01-01

Anti-MUC1 Antibody in Nipple Aspirate Fluids Correlates with Tumor Aggressiveness in Breast Cancer: A Feasibility Study

by Ebru Menekse, John McKolanis, Olivera J. Finn, Priscilla F. McAuliffe, Ronald Johnson, Atilla Soran
Published 2015-01-01

Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer

by Peiwen Ma, Peiwen Ma, Pamela L. Beatty, John McKolanis, Randal Brand, Robert E. Schoen, Olivera J. Finn
Published 2019-06-01

The “Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020

by Paolo A. Ascierto, Joshua Brody, Lisa H. Butterfield, Olivera J. Finn, John Goldberg, Francesco Perrone, Ryan J. Sullivan, Bernard A. Fox, Patrick Hwu, Igor Puzanov
Published 2021-04-01